Belhaven Biopharma

Belhaven Biopharma company information, Employees & Contact Information

Belhaven Biopharma is developing a portfolio of dry powder nasal medicines to provide convenient, safe, and rapid treatments in emergency situations

Company Details

Employees
12
Founded
-
Address
Research Triangle Park, Nc 27709, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Research Triangle Park, NC
Looking for a particular Belhaven Biopharma employee's phone or email?

Belhaven Biopharma Questions

News

Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval - Yahoo Finance

Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval Yahoo Finance

Belhaven Biopharma to Present Promising Phase 1 Data on Needle-Free Epinephrine Powder at ACAAI Annual Meeting - Newswire.com

Belhaven Biopharma to Present Promising Phase 1 Data on Needle-Free Epinephrine Powder at ACAAI Annual Meeting Newswire.com

Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections - ACCESS Newswire

Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections ACCESS Newswire

Belhaven Biopharma Raises $11M to Advance Nasdepi(R): The Dry Powder Nasal Breakthrough for Anaphylaxis - Yahoo Finance

Belhaven Biopharma Raises $11M to Advance Nasdepi(R): The Dry Powder Nasal Breakthrough for Anaphylaxis Yahoo Finance

Belhaven Biopharma Announces Positive Data From Their Nasdepi(R) Dose Confirmation Study in Patients With and Without Allergic Rhinitis - Yahoo Finance

Belhaven Biopharma Announces Positive Data From Their Nasdepi(R) Dose Confirmation Study in Patients With and Without Allergic Rhinitis Yahoo Finance

Belhaven Biopharma’s Nasdepi(R) Named Finalist for 2024 Fierce Innovation Awards in Drug Delivery Technology - Yahoo Finance

Belhaven Biopharma’s Nasdepi(R) Named Finalist for 2024 Fierce Innovation Awards in Drug Delivery Technology Yahoo Finance

Top Belhaven Biopharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant